Lastly, we treated three cutaneous melanoma cell lines with Nutlin-3 for 24 h and investigated the mRNA expression of RFX7, RFX5, PNRC1, PDCD4 and CDKN1A as positive control (Supplementary Figure S3C). This evidence concerns the gene RFX5 and cutaneous melanoma.